Navigation Links
Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
Date:9/10/2007

PLYMOUTH MEETING, Pa., Sept. 10 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced the formation of its Trodusquemine Scientific Advisory Board (the "SAB"), consisting of leading experts in the areas of obesity, diabetes and metabolic disorders, to provide guidance on the development of trodusquemine (MSI-1436), the Company's novel small molecule drug candidate for the treatment of obesity and type 2 diabetes.

"Genaera is privileged and honored to work with this prestigious group of nationally and internationally recognized experts to guide our MSI-1436 clinical development," commented Jack Armstrong, President and CEO of Genaera. "The expertise of this advisory board is a valuable resource to help ensure Genaera adopts the most scientifically focused and clinically effective development plan as we move forward with this unique therapeutic agent."

"With more than 60 million Americans classified as obese, there is a critical need for innovative therapies to manage metabolic disorders," noted Dr. Thomas Wadden, Professor of Psychology and Director of the Center for Weight Loss and Eating Disorders at the University of Pennsylvania. "I am pleased to serve on Genaera's SAB to provide direction on the current and future development of this therapeutic agent for the treatment of both obesity and type 2 diabetes."

"Despite recent advances, obesity and diabetes remain major global health issues," stated Dr. Louis Aronne, Clinical Professor of Medicine at the Weill Cornell Medical College. "Targeting these areas for future clinical research will have a major public health impact. Although early in development, trodusquemine is among the promising therapies in development for the trea
'/>"/>

SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Genaera Discontinues Lomucin in Cystic Fibrosis Studies
2. PM announces a new health care order for India
3. PowderMed Announces Needle-Less Flu Vaccine
4. Ramdoss Announces Introduction of RCH-II
5. Britain Announces Third Transfusion Related Mad Cow Case
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
11. Australian Government Announces Survey To Tackle Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Houston, TX (PRWEB) August 27, 2014 ... The reality is that depression has a mortality ... those with bi-polar disorder is slightly less, though it's ... of roughly 7%. In order to properly treat ... schizophrenia, and bi-polar, medication must be taken as directed. ...
(Date:8/27/2014)... Illinois (PRWEB) August 27, 2014 Aspirus ... project in the US with Buzz™ Digital O.R. at ... foundation of all 13 new operating rooms will be ... and management. This integrative system supports planning, navigation, imaging ... an advanced fusion of intuitive software and hardware all ...
(Date:8/27/2014)... of the leading purveyors of real and synthetic hair wigs, hair ... its products, for the coming Labor Day. , People searching for ... hair products in two ways: when they spend more than $89 ... LABOR10; while when they spend more than $299, they can save ... code is needed when securely checkout, there are about 50 products ...
(Date:8/27/2014)... is the second leading cause of cancer-associated death ... the difficulty in treating this cancer using conventional ... etoposide or combinations therein. This may be attributed ... to reach in a sufficient concentration in the ... harmful to the rest of the body. Considering ...
(Date:8/27/2014)... which repel water and oil and are persistent ... processing. These characteristics have made the fluorochemicals useful ... for food paper and board. , The problem ... break down and accumulate in both humans and ... harmful health effects, such as cancer, increased cholesterol ...
Breaking Medicine News(10 mins):Health News:MedicationDiscountCard.com now Makes Brintellix and Mental Illness Medications More Affordable with Discount Cards 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:UniWigs Is Offering A Big Sale for Labor Day on All Its Products 2Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 2Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 3Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 2Health News:Leading scientists call for a stop to non-essential use of fluorochemicals 3
... study report based on detainee interrogations finds that ... not involve physical pain—such as psychological// manipulation, deprivation, ... much mental distress and traumatic stress as physical ... torture encompass both physical and mental pain and ...
... that nearly four out of five hospitalized children receive ... adults//. The authors fear that treating children with off-label ... the magnitude of off-label use of drugs in children," ... specializing in infectious diseases at The Children’s Hospital of ...
... been a success, but continued commitment from the government is ... officials. ,The Immunization Plus Days (IPDs) initiative was ... (NPI) ¯ a government initiative with support from UNICEF and ... 18 northern regions still affected by the virus. ...
... Scientists have developed a test for the early diagnosis of lung ... and off in cells// lining the airways leading to the lungs ... effective. ,Lung cancer is the most deadly form of ... men and the third most common in women. In 2002 about ...
... University researchers have released results of a study showing ... intake//, higher body weight, a decrease in calcium and ... ,The report also noted that studies funded ... show detrimental effects from soft drinks than studies that ...
... the accurate amount of fat in a human body, according// to ... for measuring the amount of fat in a person's body. It ... of their height. ,Generally, a BMI of 25 or ... A person with a higher BMI is thought to be at ...
Cached Medicine News:Health News:All Forms of Ill Treatment Cause Post Traumatic Stress Disorder-PTSD 2Health News:All Forms of Ill Treatment Cause Post Traumatic Stress Disorder-PTSD 3Health News:Prescribing Off Label Drugs for Children may Be Hazardous 2Health News:Prescribing Off Label Drugs for Children may Be Hazardous 3Health News:Nigerian Programme Increases Polio Immunisation 2Health News:Gene Cell Test may Aid Early Lung Cancer Diagnosis 2Health News:Yale Researchers Weigh the Science on Soft Drinks and Health 2
(Date:8/27/2014)... Aug. 27, 2014 Ambit Biosciences (Nasdaq: AMBI ... drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, ... Care Conference to be held at The New York Palace ... September 3-4, 2014. Alan Fuhrman , Ambit,s ... lead drug candidate, quizartinib, at 1:10 p.m. ET on Wednesday, ...
(Date:8/27/2014)... -- After the February 2014 launch of their new ... medical practices and management companies, Prime Clinical is reporting ... "The feedback has been great," says Director of ... of demos and new sign-ups is a reflection of ... of software features." Prime Clinical developed ...
(Date:8/27/2014)... 27, 2014  Zimmer Holdings, Inc. (NYSE and SIX: ... it will be participating in the Morgan Stanley 2014 ... New York, New York , on Tuesday, ... CEO of Zimmer, will be presenting at 9:10 a.m. ... of Biomet, will join Mr. Dvorak for the Q&A ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
For the quantitative determination of Gamma Glutamyltransferase in serum or plasma...
The CK method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase activity in serum and plasma...
The XCHO method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of cholesterol in serum and plasma....
For the quantitative in vitro determination of Cholesterol in serum and plasma....
Medicine Products: